STAAR Surgical Board Asks Shareholders to Approve Planned Alcon Merger

MT Newswires Live
Sep 16, 2025

STAAR Surgical (STAA) said Tuesday its board unanimously recommends that shareholders approve the planned merger with Alcon (ALC), which it says is in the best interests of the company.

STAAR said it has filed a definitive proxy statement with the US Securities and Exchange Commission for the deal. There will be a special shareholder meeting on Oct. 23 to vote on the merger, it said.

On Aug. 5, STAAR said it agreed to be bought by Alcon for $28 per share in cash.

Price: 27.56, Change: -0.11, Percent Change: -0.40

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10